| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 11 | 2026 | 1275 | 1.570 |
Why?
|
| Takotsubo Cardiomyopathy | 6 | 2023 | 69 | 1.540 |
Why?
|
| Pericardium | 5 | 2023 | 35 | 1.390 |
Why?
|
| Atrial Fibrillation | 8 | 2026 | 884 | 1.360 |
Why?
|
| Coronary Artery Disease | 4 | 2026 | 326 | 1.330 |
Why?
|
| Ventricular Remodeling | 5 | 2026 | 95 | 1.250 |
Why?
|
| Cardiomyopathies | 4 | 2023 | 137 | 1.210 |
Why?
|
| Intra-Abdominal Fat | 2 | 2019 | 37 | 1.000 |
Why?
|
| Ventricular Function, Left | 5 | 2026 | 284 | 0.820 |
Why?
|
| Adiposity | 3 | 2026 | 89 | 0.810 |
Why?
|
| Heart Failure | 5 | 2026 | 962 | 0.740 |
Why?
|
| Blood Vessels | 2 | 2014 | 63 | 0.730 |
Why?
|
| Heart Valve Diseases | 3 | 2023 | 93 | 0.730 |
Why?
|
| Electrocardiography | 7 | 2022 | 555 | 0.710 |
Why?
|
| Adipose Tissue | 5 | 2023 | 300 | 0.700 |
Why?
|
| Cardiovascular Diseases | 3 | 2014 | 867 | 0.680 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 179 | 0.660 |
Why?
|
| Pheochromocytoma | 1 | 2020 | 31 | 0.650 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2020 | 51 | 0.630 |
Why?
|
| Lipolysis | 1 | 2020 | 47 | 0.620 |
Why?
|
| Diagnostic Imaging | 2 | 2013 | 272 | 0.620 |
Why?
|
| Atherosclerosis | 3 | 2016 | 162 | 0.620 |
Why?
|
| Echocardiography | 5 | 2023 | 513 | 0.590 |
Why?
|
| Echocardiography, Doppler | 2 | 2018 | 133 | 0.560 |
Why?
|
| Insulin | 2 | 2020 | 695 | 0.550 |
Why?
|
| Vascular Diseases | 2 | 2016 | 83 | 0.550 |
Why?
|
| Coronary Angiography | 4 | 2026 | 212 | 0.540 |
Why?
|
| Adipocytes | 4 | 2023 | 274 | 0.510 |
Why?
|
| Adipose Tissue, Brown | 2 | 2023 | 124 | 0.490 |
Why?
|
| Humans | 40 | 2026 | 65463 | 0.480 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2016 | 8 | 0.480 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2016 | 23 | 0.470 |
Why?
|
| Methylprednisolone | 1 | 2015 | 37 | 0.460 |
Why?
|
| Bradycardia | 1 | 2015 | 33 | 0.450 |
Why?
|
| Insulin Resistance | 2 | 2016 | 415 | 0.450 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2015 | 42 | 0.440 |
Why?
|
| Cardiac Catheterization | 2 | 2016 | 292 | 0.420 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2016 | 235 | 0.410 |
Why?
|
| Glucocorticoids | 1 | 2015 | 190 | 0.410 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2014 | 115 | 0.400 |
Why?
|
| Diastole | 3 | 2023 | 90 | 0.400 |
Why?
|
| Lectins, C-Type | 1 | 2013 | 79 | 0.390 |
Why?
|
| Antigens, Neoplasm | 1 | 2013 | 135 | 0.380 |
Why?
|
| Aortic Valve Stenosis | 2 | 2026 | 190 | 0.380 |
Why?
|
| Multiple Sclerosis | 1 | 2015 | 227 | 0.380 |
Why?
|
| Inflammation | 4 | 2017 | 1193 | 0.370 |
Why?
|
| Myocardial Infarction | 2 | 2017 | 921 | 0.370 |
Why?
|
| Outpatients | 1 | 2013 | 143 | 0.370 |
Why?
|
| Ventricular Premature Complexes | 2 | 2022 | 20 | 0.340 |
Why?
|
| Macrophages | 2 | 2016 | 1038 | 0.330 |
Why?
|
| Photoplethysmography | 3 | 2026 | 38 | 0.330 |
Why?
|
| Male | 22 | 2026 | 31187 | 0.320 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2026 | 99 | 0.310 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 526 | 0.310 |
Why?
|
| Thinness | 1 | 2009 | 44 | 0.300 |
Why?
|
| Thermogenesis | 3 | 2023 | 127 | 0.300 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2020 | 169 | 0.290 |
Why?
|
| Heart Failure, Diastolic | 1 | 2009 | 9 | 0.290 |
Why?
|
| Female | 22 | 2026 | 34193 | 0.290 |
Why?
|
| Middle Aged | 15 | 2026 | 18387 | 0.290 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2009 | 50 | 0.280 |
Why?
|
| Body Mass Index | 2 | 2026 | 899 | 0.280 |
Why?
|
| Aged | 15 | 2026 | 15052 | 0.270 |
Why?
|
| Heart Atria | 3 | 2023 | 137 | 0.270 |
Why?
|
| Prognosis | 5 | 2026 | 1789 | 0.270 |
Why?
|
| Diet | 1 | 2011 | 536 | 0.260 |
Why?
|
| Predictive Value of Tests | 3 | 2026 | 1114 | 0.260 |
Why?
|
| Stroke Volume | 2 | 2018 | 342 | 0.250 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2019 | 542 | 0.240 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2026 | 12 | 0.240 |
Why?
|
| Atrial Remodeling | 1 | 2026 | 23 | 0.240 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2026 | 25 | 0.230 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2026 | 20 | 0.230 |
Why?
|
| Wearable Electronic Devices | 2 | 2026 | 77 | 0.230 |
Why?
|
| Coronary Stenosis | 1 | 2026 | 41 | 0.230 |
Why?
|
| Histone Deacetylases | 1 | 2025 | 67 | 0.220 |
Why?
|
| Coronary Vessels | 1 | 2026 | 125 | 0.220 |
Why?
|
| Energy Metabolism | 2 | 2025 | 399 | 0.220 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2026 | 162 | 0.210 |
Why?
|
| Computed Tomography Angiography | 1 | 2026 | 141 | 0.210 |
Why?
|
| Metformin | 1 | 2025 | 77 | 0.210 |
Why?
|
| Systole | 2 | 2015 | 109 | 0.210 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2009 | 708 | 0.210 |
Why?
|
| Animals | 12 | 2026 | 21381 | 0.210 |
Why?
|
| Heart Ventricles | 3 | 2023 | 267 | 0.200 |
Why?
|
| Heart Valves | 2 | 2023 | 26 | 0.190 |
Why?
|
| Glutamine | 1 | 2023 | 50 | 0.190 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2023 | 45 | 0.190 |
Why?
|
| Fibrosis | 1 | 2023 | 172 | 0.180 |
Why?
|
| Epigenesis, Genetic | 1 | 2025 | 410 | 0.180 |
Why?
|
| Massachusetts | 4 | 2013 | 2153 | 0.180 |
Why?
|
| Myocardial Ischemia | 2 | 2017 | 121 | 0.170 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2021 | 3 | 0.170 |
Why?
|
| Infarction, Posterior Cerebral Artery | 1 | 2021 | 7 | 0.170 |
Why?
|
| Glucose | 2 | 2023 | 477 | 0.170 |
Why?
|
| Atrial Premature Complexes | 1 | 2021 | 12 | 0.170 |
Why?
|
| Prevalence | 4 | 2026 | 1451 | 0.170 |
Why?
|
| Risk Assessment | 4 | 2026 | 2111 | 0.170 |
Why?
|
| Adrenergic Agents | 1 | 2020 | 15 | 0.160 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2020 | 7 | 0.160 |
Why?
|
| Diet, Reducing | 1 | 2020 | 25 | 0.160 |
Why?
|
| Uncoupling Protein 1 | 3 | 2020 | 51 | 0.150 |
Why?
|
| Mice | 9 | 2026 | 11138 | 0.150 |
Why?
|
| Genetic Vectors | 1 | 2026 | 925 | 0.150 |
Why?
|
| Hypertension | 1 | 2005 | 616 | 0.150 |
Why?
|
| Oxygen Consumption | 2 | 2020 | 213 | 0.150 |
Why?
|
| Subcutaneous Fat | 1 | 2019 | 50 | 0.150 |
Why?
|
| Dependovirus | 1 | 2026 | 758 | 0.150 |
Why?
|
| Weight Gain | 1 | 2020 | 165 | 0.150 |
Why?
|
| Risk Factors | 5 | 2026 | 5458 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 5 | 2026 | 3488 | 0.140 |
Why?
|
| Cytokines | 3 | 2017 | 951 | 0.140 |
Why?
|
| Genetic Therapy | 1 | 2026 | 849 | 0.140 |
Why?
|
| Muscle, Skeletal | 2 | 2023 | 787 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2019 | 297 | 0.140 |
Why?
|
| Apolipoproteins E | 2 | 2015 | 115 | 0.140 |
Why?
|
| Aged, 80 and over | 6 | 2026 | 5644 | 0.140 |
Why?
|
| RNA, Long Noncoding | 1 | 2020 | 170 | 0.130 |
Why?
|
| Severity of Illness Index | 3 | 2026 | 1564 | 0.130 |
Why?
|
| Heart Rate | 3 | 2026 | 334 | 0.130 |
Why?
|
| Algorithms | 4 | 2026 | 1050 | 0.130 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2017 | 98 | 0.130 |
Why?
|
| Lectins | 1 | 2017 | 43 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 84 | 0.130 |
Why?
|
| Adipogenesis | 1 | 2018 | 81 | 0.130 |
Why?
|
| Prospective Studies | 3 | 2026 | 3324 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 796 | 0.120 |
Why?
|
| Pulse Therapy, Drug | 1 | 2015 | 4 | 0.120 |
Why?
|
| Stem Cells | 1 | 2018 | 276 | 0.120 |
Why?
|
| Interferon Type I | 1 | 2017 | 197 | 0.120 |
Why?
|
| NADPH Oxidases | 1 | 2015 | 69 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 113 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 132 | 0.110 |
Why?
|
| Ion Channels | 2 | 2016 | 92 | 0.110 |
Why?
|
| Glucose Intolerance | 1 | 2016 | 90 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2016 | 152 | 0.110 |
Why?
|
| Infusions, Intravenous | 1 | 2015 | 192 | 0.110 |
Why?
|
| Time Factors | 3 | 2018 | 3774 | 0.110 |
Why?
|
| Mitochondrial Proteins | 2 | 2016 | 109 | 0.110 |
Why?
|
| Brain Ischemia | 1 | 2018 | 418 | 0.110 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 237 | 0.100 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 225 | 0.100 |
Why?
|
| Endothelial Cells | 1 | 2015 | 213 | 0.100 |
Why?
|
| Mice, Knockout | 4 | 2025 | 2162 | 0.100 |
Why?
|
| Pancreatitis-Associated Proteins | 1 | 2013 | 5 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 2492 | 0.100 |
Why?
|
| Autophagy | 1 | 2016 | 237 | 0.100 |
Why?
|
| Blood Glucose | 1 | 2016 | 502 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2016 | 1575 | 0.090 |
Why?
|
| ROC Curve | 1 | 2013 | 292 | 0.090 |
Why?
|
| Cause of Death | 1 | 2013 | 221 | 0.090 |
Why?
|
| Treatment Outcome | 2 | 2016 | 5806 | 0.090 |
Why?
|
| Registries | 2 | 2026 | 929 | 0.090 |
Why?
|
| Mitochondria, Heart | 1 | 2011 | 14 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2011 | 65 | 0.090 |
Why?
|
| Survival Rate | 1 | 2013 | 847 | 0.080 |
Why?
|
| Torsades de Pointes | 1 | 2010 | 6 | 0.080 |
Why?
|
| Aorta, Thoracic | 1 | 2011 | 80 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 139 | 0.080 |
Why?
|
| Neutrophil Infiltration | 1 | 2011 | 64 | 0.080 |
Why?
|
| Long QT Syndrome | 1 | 2010 | 31 | 0.080 |
Why?
|
| Retrospective Studies | 5 | 2018 | 6929 | 0.080 |
Why?
|
| Dietary Fats | 1 | 2011 | 181 | 0.080 |
Why?
|
| Aortic Valve | 2 | 2025 | 181 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2011 | 663 | 0.080 |
Why?
|
| Stroke | 1 | 2018 | 1213 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2020 | 2188 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 897 | 0.070 |
Why?
|
| Heart Failure, Systolic | 1 | 2009 | 16 | 0.070 |
Why?
|
| Cardiotonic Agents | 1 | 2009 | 54 | 0.070 |
Why?
|
| Homeostasis | 2 | 2025 | 380 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2026 | 2305 | 0.070 |
Why?
|
| Disease Progression | 1 | 2013 | 1223 | 0.070 |
Why?
|
| Acute Disease | 1 | 2009 | 663 | 0.070 |
Why?
|
| Biomarkers | 1 | 2013 | 1481 | 0.070 |
Why?
|
| Odds Ratio | 1 | 2009 | 755 | 0.070 |
Why?
|
| Stress, Physiological | 1 | 2009 | 210 | 0.060 |
Why?
|
| Ultrasonography | 1 | 2009 | 491 | 0.060 |
Why?
|
| Logistic Models | 1 | 2009 | 1273 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 990 | 0.060 |
Why?
|
| Aorta | 2 | 2018 | 108 | 0.060 |
Why?
|
| Vasodilator Agents | 1 | 2026 | 70 | 0.060 |
Why?
|
| Europe | 1 | 2026 | 199 | 0.060 |
Why?
|
| Age Factors | 1 | 2009 | 1592 | 0.060 |
Why?
|
| Acetylation | 1 | 2025 | 121 | 0.060 |
Why?
|
| Transgenes | 1 | 2026 | 207 | 0.060 |
Why?
|
| Hospital Mortality | 1 | 2009 | 879 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2009 | 475 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2026 | 501 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2025 | 148 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2026 | 175 | 0.050 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2026 | 110 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2014 | 3155 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2026 | 589 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2025 | 422 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2026 | 687 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2026 | 308 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2009 | 2633 | 0.050 |
Why?
|
| Histones | 1 | 2025 | 495 | 0.040 |
Why?
|
| Artifacts | 1 | 2022 | 128 | 0.040 |
Why?
|
| Mitochondria | 1 | 2025 | 410 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 1631 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2026 | 1710 | 0.040 |
Why?
|
| Perilipin-1 | 1 | 2020 | 11 | 0.040 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2020 | 52 | 0.040 |
Why?
|
| Lipid Droplets | 1 | 2020 | 35 | 0.040 |
Why?
|
| Adult | 3 | 2026 | 17461 | 0.040 |
Why?
|
| Cell Communication | 1 | 2020 | 133 | 0.040 |
Why?
|
| Machine Learning | 1 | 2021 | 195 | 0.040 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2017 | 54 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2017 | 38 | 0.030 |
Why?
|
| Adipokines | 1 | 2017 | 36 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2018 | 216 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2020 | 631 | 0.030 |
Why?
|
| Proprotein Convertase 1 | 1 | 2016 | 7 | 0.030 |
Why?
|
| Enkephalins | 1 | 2016 | 20 | 0.030 |
Why?
|
| Interleukin-33 | 1 | 2016 | 19 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2016 | 19 | 0.030 |
Why?
|
| Iodide Peroxidase | 1 | 2016 | 23 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 2016 | 41 | 0.030 |
Why?
|
| Glucose Clamp Technique | 1 | 2016 | 57 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2015 | 35 | 0.030 |
Why?
|
| Capillaries | 1 | 2016 | 34 | 0.030 |
Why?
|
| Integrin beta1 | 1 | 2016 | 32 | 0.030 |
Why?
|
| Adipocytes, White | 1 | 2016 | 27 | 0.030 |
Why?
|
| Aminopyridines | 1 | 2015 | 34 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2016 | 97 | 0.030 |
Why?
|
| NADPH Oxidase 4 | 1 | 2015 | 7 | 0.030 |
Why?
|
| Protein Precursors | 1 | 2016 | 85 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 233 | 0.030 |
Why?
|
| United States | 1 | 2009 | 8148 | 0.030 |
Why?
|
| Adipocytes, Brown | 1 | 2016 | 46 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 108 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2023 | 1557 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 180 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 211 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 513 | 0.030 |
Why?
|
| Transcriptome | 1 | 2018 | 399 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2015 | 177 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 611 | 0.030 |
Why?
|
| Phenotype | 1 | 2018 | 1233 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2015 | 435 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2015 | 321 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2015 | 574 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2015 | 221 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 732 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 1290 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2015 | 1039 | 0.020 |
Why?
|
| Proteins | 1 | 2016 | 764 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 4837 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 1225 | 0.020 |
Why?
|